1. Zhang, Weihao, Xie, Yongjie, Yu, Xin, Xing, Wenge, Si, Tongguo. 2023. ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer. In Discover oncology, 14, 87. doi:10.1007/s12672-023-00690-7. https://pubmed.ncbi.nlm.nih.gov/37273016/
2. Moreland, Ethan, Borisov, Oleg V, Semenova, Ekaterina A, Williams, Alun G, Ahmetov, Ildus I. 2020. Polygenic Profile of Elite Strength Athletes. In Journal of strength and conditioning research, 36, 2509-2514. doi:10.1519/JSC.0000000000003901. https://pubmed.ncbi.nlm.nih.gov/33278272/
3. Bian, Jing, Xiong, Wenji, Yang, Zhiguang, Zhang, Yanli, Liu, Chaoying. 2024. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma. In Scientific reports, 14, 522. doi:10.1038/s41598-024-51182-9. https://pubmed.ncbi.nlm.nih.gov/38177255/
4. Jiang, Feng, Huang, Xiaolu, Zhang, Fan, Chen, Jie, Wang, Yumin. 2022. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer. In DNA and cell biology, 41, 305-318. doi:10.1089/dna.2021.0878. https://pubmed.ncbi.nlm.nih.gov/35104421/
5. Lin, David Tse Shen, Conibear, Elizabeth. 2015. ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. In eLife, 4, e11306. doi:10.7554/eLife.11306. https://pubmed.ncbi.nlm.nih.gov/26701913/
智鼠故事 
